Gene · 3704
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations. | J Tradit Complement Med | 2022 | 34926189 | PubTator, text mining | PubMed |
| The lysine at position 151 of the duck hepatitis A virus 1 2C protein is critical for its NTPase activities. | Vet Microbiol | 2022 | 34922149 | PubTator, text mining | PubMed |
| The function of chloroplast ferredoxin-NADP+ oxidoreductase positively regulates the accumulation of bamboo mosaic virus in Nicotiana benthamiana. | Mol Plant Pathol | 2022 | 34918877 | PubTator, text mining | PubMed |
| Structural Basis of Zika Virus Helicase in RNA Unwinding and ATP Hydrolysis. | ACS Infect Dis | 2022 | 34904824 | PubTator, text mining | PubMed |
| Flavonoids and ω3-polyunsaturated fatty acid supplementation in renal transplant recipients: new arguments from COVID-19. | J Nephrol | 2022 | 34773603 | PubTator, text mining | PubMed |
| Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta. | J Ethnopharmacol | 2022 | 34737005 | PubTator, text mining | PubMed |
| Complete genome sequence of GII.9 norovirus. | Arch Virol | 2022 | 34718885 | PubTator, text mining | PubMed |
| ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia. | Pediatr Hematol Oncol | 2022 | 34665987 | PubTator, text mining | PubMed |
| Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. | Hepatology | 2022 | 34633706 | PubTator, text mining | PubMed |
| TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results. | Clin Pharmacol Ther | 2022 | 34582038 | PubTator, text mining | PubMed |
| Conserved motifs in the flavivirus NS3 RNA helicase enzyme. | Wiley Interdiscip Rev RNA | 2022 | 34472205 | PubTator, text mining | PubMed |
| Exploring the Role of Heavy Metals and Their Derivatives on the Pathophysiology of COVID-19. | Biol Trace Elem Res | 2022 | 34448983 | PubTator, text mining | PubMed |
| Evaluation of potency of the selected bioactive molecules from Indian medicinal plants with MPro of SARS-CoV-2 through in silico analysis. | J Ayurveda Integr Med | 2022 | 34054246 | PubTator, text mining | PubMed |
| Array-Based Comparative Genomic Hybridization Analysis in Children with Developmental Delay/Intellectual Disability. | Balkan J Med Genet | 2021 | 36249514 | PubTator, text mining | PubMed |
| Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases. | RSC Adv | 2021 | 35492479 | PubTator, text mining | PubMed |
| Multi-Targeted Approaches and Drug Repurposing Reveal Possible SARS-CoV-2 Inhibitors. | Vaccines (Basel) | 2021 | 35062685 | PubTator, text mining | PubMed |
| Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review. | Viruses | 2021 | 35062249 | PubTator, text mining | PubMed |
| A Structural Perspective of Reps from CRESS-DNA Viruses and Their Bacterial Plasmid Homologues. | Viruses | 2021 | 35062241 | PubTator, text mining | PubMed |
| Transcriptomic and Metabolomic Profiling in Helicobacter pylori-Induced Gastric Cancer Identified Prognosis- and Immunotherapy-Relevant Gene Signatures. | Front Cell Dev Biol | 2021 | 35004676 | PubTator, text mining | PubMed |
The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors. | Cancer Drug Resist | 2021 | 34993424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3704/papers?page=20